Teva Reinforces Leadership Position in CNS with Acquisition of Auspex
Go back to Teva Reinforces Leadership Position in CNS with Acquisition of Auspex| AUSPEX PHARM (NASDAQ: ASPX) | Delayed: 100.96 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $100.96 | 52 Week High | $101.00 | |||
| Open | $22.00 | 52 Week Low | $14.75 | |||
| Day High | $100.96 | P/E | N/A | |||
| Day Low | $100.96 | EPS | $-2.82 | |||
| Volume | 658,339 | |||||
| TEVA PHARMACEUTICAL INDUSTRIES (NYSE: TEVA) | Delayed: 36.34 -0.28 (0.76%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $36.62 | 52 Week High | $66.55 | |||
| Open | $36.40 | 52 Week Low | $37.82 | |||
| Day High | $36.93 | P/E | N/A | |||
| Day Low | $36.13 | EPS | $0.00 | |||
| Volume | 1,786,115 | |||||
